Effectiveness of post-partum family planning interventions on contraceptive use and method mix at 1 year after childbirth in Kinshasa, DR Congo (Yam Daabo): a single-blind, cluster-randomised controlled trial. by Tran, NT et al.
www.thelancet.com/lancetgh   Vol 8   March 2020 e399
Articles
Effectiveness of post-partum family planning interventions 
on contraceptive use and method mix at 1 year after 
childbirth in Kinshasa, DR Congo (Yam Daabo): a single-blind, 
cluster-randomised controlled trial
Nguyen Toan Tran, Armando Seuc, Béatrice Tshikaya, Maurice Mutuale, Sihem Landoulsi, Brigitte Kini, Bernadette Mbu Nkolomonyi, 
Jean Nyandwe Kyloka, Félicité Langwana, Asa Cuzin-Kihl, James Kiarie, Mary Eluned Gaffield, Rachel Yodi, Désiré Mashinda Kulimba
Summary
Background In rural Burkina Faso, a package of six low-technology, post-partum contraceptive interventions 
(ie, refresher training for providers, a counselling tool, supportive supervision, daily availability of contraceptive 
services, client appointment cards, and invitation letters to attend appointments for partners), aimed at strengthening 
existing primary health-care services and enhancing demand for them, doubled the use of modern contraceptives at 
12 months post partum (ie, 55% uptake in intervention recipients vs 29% in routine-care users). This study assessed 
the effect of a similar package but in urban settings of Kinshasa province, Democratic Republic of the Congo, in an 
effort to reduce the unmet need for post-partum family planning.
Methods Yam Daabo was a multi-intervention, single-blinded, cluster-randomised controlled trial done in six 
primary health-care centres (clusters) in Kinshasa. Centres were randomly allocated to receive the six-component 
intervention or standard antenatal and postnatal care in matched pairs (1:1) on the basis of number of monthly 
births, the ratio of health workers per population in the health zone, and the urban and suburban settings. Only 
data analysts could be masked to cluster allocation. Health-care facilities were eligible if they provided a continuum 
of antenatal, delivery, and postnatal care, were well stocked with contraceptives, and were situated close to the main 
study centre. All pregnant women presenting to the six centres were eligible if they were in their third pregnancy 
trimester and had no counterindications to deliver in the facility. The main outcome was prevalence of use of 
modern contraceptives at 12 months after delivery. Analysis was by modified intention-to-treat using generalised 
linear mixed models or Fisher’s exact test for small groups. Prevalence ratios were adjusted for cluster effects 
and baseline characteristics. This study was registered with the Pan-African Clinical Trials Registry 
(PACTR201609001784334).
Findings From July 1, 2016, to Feb 2, 2017, eight of 52 clinics assessed for eligibility met the criteria and were 
randomised. Of 690 women approached, 576 (83%) women were enrolled: 286 in the four intervention clusters and 
290 in the four control clusters. Of them, 519 (90%) completed the 12-month study exit interview (252 in the 
intervention group and 267 in the control group) and were included in the intention-to-treat analysis. At 12 months, 
115 (46%) of 252 women in the intervention group and 94 (35%) of 267 in the control group were using modern 
contraceptives (adjusted prevalence ratio [PR] 1∙58, 95% CI 0∙74−3∙38), with significant differences in the use of 
contraceptive implants (22% vs 6%; adjusted PR 4∙36, 95% CI 1∙96–9∙70), but without difference in the use of short-
acting contraceptives (23% vs 28%; 0∙92, 0∙29–2∙98) and non-modern or inappropriate methods (7% vs 18%; 0∙45, 
0∙13–1∙54). There were no serious adverse events or maternal deaths related to the study.
Interpretation The Yam Daabo intervention package did not have a significant effect on the overall use of effective 
modern contraceptives but significantly increased implant use in women post partum who live in urban settings in 
Kinshasa up to a year after childbirth. However, interferences from external family planning initiatives in the control 
group might have diminished differences between the services received. Such an intervention could be potentially 
relevant in similar contexts in DR Congo and other countries.
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Introduction
Post-partum family planning is defined by WHO as the 
prevention of closely-spaced pregnancies and unwanted 
pregnancies up to 12 months after delivery, when a new 
pregnancy presents high risk for mothers and babies. 
Post-partum family planning could prevent more than 
30% of maternal and 10% of infant deaths by effectively 
spacing birth-to-pregnancy intervals by at least 2 years and 
birth-to-birth intervals by at least 3 years.1 Therefore, post-
partum family planning services aim to assist women 
and couples to decide on their preferred method of 
contraception, initiate that method, and continue use for 
ideally 2 years or longer, depending on their reproductive 
goals.2 Birth-to-pregnancy intervals in 50% or more of 
pregnancies in low-income and middle-income countries 
are too short (<23 months).3 Considering the definition 
that assumes that the risk of becoming pregnant restarts 
soon after birth and before the sixth week post partum, 
and that women should use contraception even if 
abstinent or before the menstrual cycle resumes, unmet 
need for family planning reaches 65% in east and 
southern Africa and 75% in west and central Africa.4
Post-partum family planning is usually designed as an 
integral part of reproductive, maternal, neonatal, and 
child health services. Despite some progress in accessing 
these services in sub-Saharan African countries, improve-
ment in reducing the unmet need for effective post-
partum contraceptives is slow.5 According to various 
literature reviews, the evidence is often weak or incomplete 
in terms of research design and quality, details about the 
interventions, or women’s pers pectives.6–8 There is also a 
paucity of studies looking at operationally feasible ways to 
integrate post-partum family planning into existing 
antenatal and postnatal care, for example through 
meaningful involvement of community actors.2 In 
response, the Yam Daabo trial (meaning “your choice” in 
Mooré, one of the local languages in Burkina Faso) was 
designed to test the effectiveness of a low-technology, post-
partum family planning intervention package, established 
using participatory action research, on contraceptive 
uptake.9 In predominantly rural settings in Burkina Faso, 
results showed that the use of modern contraceptives 
almost doubled at 12 months post partum, reaching 55% 
of women in the intervention group versus 29% of women 
who received routine care in the control group (adjusted 
prevalence ratio 1∙79, 95% CI 1∙30–2∙47).9 Significant 
differences were also found in the proportion of women 
in the two groups using long-acting contra ceptives, mostly 
implants (29% vs 17%), and short-acting methods 
(26% vs 12%), with injectables prevailing.
Research in context
Evidence before this study
We searched PubMed for papers published since inception to 
April 1, 2019, using the term “randomized controlled trial” 
combined with “post partum” and “contraception” or “family 
planning” for publications in English focusing on trials in 
low-income and middle-income countries. We identified six trials 
since the most recent systematic review at the time, which was 
published in 2016. All six trials were in Africa and investigated a 
specific intervention: men’s involvement in maternity care in 
Burkina Faso; advance counselling and provision of emergency 
contraceptive pills in Egypt; integration of post-partum family 
planning in immunisation clinics in Rwanda; implant services 
after childbirth in Uganda; and two Kenyan studies investigating 
weekly mobile phone text message reminders, and text message 
reminders combined with vouchers for modern contraceptives. 
Effectiveness was shown in all studies except for the Kenyan 
study testing text messaging alone. The urban-based study in 
Burkina Faso, which is particularly relevant to our trial, involved 
male partners of pregnant women in maternity care through 
men-only group sessions and provided couple counselling 
sessions before and after delivery. Results showed that the use of 
any contraceptives at 8 months post partum was marginally 
different between the intervention group (71%) and control 
group (64%), with a risk ratio of 1·10 (95% CI 1·02–1·20).
Added value of this study
By contrast, the Yam Daabo trial, implemented in 
predominantly rural areas in Burkina Faso and in urban 
settings in the Democratic Republic of the Congo, did not 
investigate a specific programmatic innovation or the 
promotion of a particular post-partum family planning 
method. Instead, fertility and contraceptive choices were made 
by the women and couples. Results of this cluster-randomised 
controlled trial in Kinshasa province showed that a package 
strategy consisting of six low-technology interventions 
designed in a participatory manner and aimed at 
strengthening routine antenatal and postnatal care services 
in primary health clinics could decrease the unmet need for 
post-partum family planning and contribute to reducing 
maternal and newborn mortality and morbidity through 
healthy timing and spacing of pregnancies.
Implications of all the available evidence
On the basis of the growing body of evidence on post-partum 
family planning, decision makers can opt for different 
strategies to strengthen contraceptive use depending on 
health service needs, gaps, and opportunities of specific 
contexts. This includes the Yam Daabo strategy, which was 
tested and found to be effective in both rural and urban 
settings in sub-Saharan Africa. Although cost-effectiveness of 
the package warrants further study, the simplicity of the 
interventions and focus on strengthening existing services at 
the primary health-care level make them suitable for large 
scale implementation in similar settings in DR Congo, Burkina 
Faso, and other countries.
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The objective of our twin study was to assess the effect 
of a similar package on modern contraceptive prevalence 
in urban settings of Kinshasa province, Democratic 
Republic of the Congo, where poverty, hunger, and 
under development are important challenges.10 Demo-
graphic and Health Survey data from DR Congo (2013–14) 
show a country-wide median breastfeeding duration of 
22 months (2 months of exclusive breastfeeding), 
a median post-partum sexual abstinence of 8 months, 
and median amenorrhoea duration of 13 months.11 
The median duration of birth intervals is 31 months, but 
27% of babies are born less than 24 months after their 
previous sibling. Most women (88%) attend antenatal 
care and deliver in a health facility (80%). Around half 
(44%) of women who have given birth receive postnatal 
care within 48 h of delivery, and 45% of children aged 
12–23 months are adequately immunised. Despite the 
use of routine reproductive, maternal, neonatal, and 
child health services that should allow regular oppor-
tunities to address the contraceptive needs of women 
and couples post partum, the unmet need for family 
planning among these women in the whole country is 
high at 66% immediately after birth, 48% after 6 months 
of amenorrhoea, and 36% at the end of amenorrhoea.12 
In Kinshasa province, 45% of married women of 
reproductive age use any type of contraceptive method 
(vs 20% of women country-wide), and 19% use a modern 
method (vs 8%). The unmet need for family planning is 
high in Kinshasa (23% of women who are married or in 
a union and want to stop or delay childbearing have no 
access to family planning services) and nationwide (28%). 
UN data show that maternal mortality is very high (693 of 
100 000 livebirths in 2015), as is total fertility (61 children 
per woman in 2016).13
Methods
Study design and participants
The Yam Daabo study was a pragmatic, cluster-
randomised, multi-interventional trial done in eight 
primary health centres offering reproductive, maternal, 
neonatal, and child health services in Kinshasa province. 
The centres were Esengo, Esperodi, Kindele, Libondi, 
Mama Mosalisi, Ntombwa Ya Maria, Saint Paul, and 
Tshimungu (figure 1, appendix p 2).14 The central research 
centre in DR Congo was based at the School of Public 
Health of the University of Kinshasa, and the overall 
research coordinating centre was at WHO headquarters 
(Geneva, Switzerland). Our post-partum family planning 
intervention package, identified during the formative 
study phase, comprised three facility-based interventions 
(ie, refresher training of service providers, regularly 
scheduled and strengthened supportive supervision of 
providers, and enhanced availability of contraceptive 
services 7 days a week), and three individual-based inter-
ventions (ie, a post-partum family planning counselling 
tool, appointment cards for women, and invitation letters 
for partners to attend appointments). The implementation 
of three of the six components favoured a cluster design 
for the trial, with randomisation at the level of the study 
centre. Furthermore, potential contamination between 
inter vention and control groups for the other 
three individual-based interventions could be minimised 
by the cluster design. The intervention package was 
offered to women allocated to the intervention group and 
routine care (information about the benefits for mothers 
and children of spacing births and provision of basic 
contraceptives) to those allocated to the control group 
(appendix pp 4–6).
Health facilities were eligible if they provided a 
continuum of antenatal, delivery, and postnatal care; had at 
least three modern contraceptive methods available, 
including a barrier method such as condoms, a short-term 
method such as pills, a long-term method such as an 
intrauterine device, and referrals for permanent methods; 
experienced no depletion of stock of contraceptives during 
the 6 months preceding the study; cumulated an average 
of at least 30 deliveries per month; were located within a 
4 h drive from the research centre; and were willing to 
participate. All pregnant women attending the clinic for 
antenatal care were invited to participate in the study. They 
were eligible if they were in their third pregnancy trimester; 
their health and pregnancy situation allowed for a birth at 
the health centre; they had the intention to attend antenatal, 
delivery, and postnatal care at the health centre; they were 
not participating in another study; and they provided 
written informed consent (verbal informed assent for 
minors aged <18 years and written assent from their 
parents or guardians).
Study approval was obtained by the School of Public 
Health (University of Kinshasa) ethics committee in DR 
Congo (reference number ESP/CE/039b/2016) and 
WHO Research Ethics Review Committee in Geneva, 
Switzerland (protocol ID RPC757). This study is 
registered with the Pan African Clinical Trials Registry 
(PACTR201609001784334).
Randomisation and masking
The eight sites were matched in pairs according to the 
number of monthly births, the ratio of health workers per 
population in the health zone, and the urban and suburban 
settings, without specific thresholds for these criteria 
(appendix p 3). Within each of the four study centre pairs, 
a site was randomly assigned to the intervention group or 
to the control group (1:1 ratio). This computer-based 
randomisation was done four times, once for each pair. No 
restriction in the randomisation process was required. All 
eligible participants consecutively presenting at the health 
centres were included in the clusters. The nature of the 
interventions did not allow masking to cluster assignment 
of participants, health staff, research assistants assigned to 
each centre, and the rest of the research team members. 
Only data analysts were masked to cluster assignment (ie, 
they received no information about the cluster allocation 
and did not interact with the field team). Masking of data 
See Online for appendix
Articles
e402 www.thelancet.com/lancetgh   Vol 8   March 2020
was achieved by replacing study site names with numbers 
and group names with letters.
Procedures
The rationale for our trial approach is based on WHO’s 
seminal 2013 publication of programmatic strategies for 
post-partum family planning2 and three other systematic 
reviews (without meta-analysis) on post-partum family 
planning interventions in low-income and middle-income 
countries published between 2014 and 2016.6–8 These 
publications suggest that the following interventions could 
have a positive effect on post-partum contraceptive uptake: 
counselling activities during antenatal care; provision of 
post-partum family planning information, education, and 
counselling materials before women are discharged from 
health facilities after birth, including provision of 
emergency contraception for women using the lactational 
amenorrhoea method; promotion by community-based 
counsellors of exclusive breastfeeding practices before 
5−6 months post partum; access to contraceptive methods 
immediately after birth, including intrauterine devices; 
provider competencies in quality counselling and the 
provision of quality services with several readily available 
products; and long programmes with several contact 
points between providers and clients across the continuum 
of care versus short antenatal interventions.
The intervention package was designed through 
participatory action research and the process and 
contents were detailed elsewhere (appendix pp 4–6).15,16 
The working hypotheses for the selection of the post-
partum family planning interventions to be included in 
the package were as follows. Interventions should 
strengthen existing antenatal and postnatal care services 































Figure 1: Kinshasa province and study area with intervention clusters (red) and control clusters (green)
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We assumed that they would be more effective than high-
dose, low-frequency strategies that promote a specific 
method over another and restrict services to a narrow 
timeframe, such as before home discharge after delivery, 
or during the 6-week postnatal care visits dedicated to 
post-partum family planning. Drawing from participatory 
action research principles,17 key actors, including clients 
and providers, should be meaningfully engaged in the 
package design, implementation, and research. Such 
participation would ensure that the package reflects field 
reality, including restricted clinical capacity and human 
and financial resources, and is feasible, sustainable, and 
scalable while also aligned with national health policies.
We followed WHO recommendations for medical 
eligibility of contraceptive use to define modern contra-
ceptives appropriate up to 12 months post partum.18 We 
categorised modern contraceptives as: long-acting and 
reversible, including implants and intrauterine devices; 
short-acting, including injectables, pills, emergency 
contraception, male and female condoms, and other less 
commonly used methods; permanent methods (male 
and female sterilisation); and lactational amenorrhoea. 
Contraceptives were further defined as modern and 
appropriate and non-modern or inappropriate. Non-
modern contraceptives used traditional methods such as 
withdrawal and abstinence. Inappropriate contraceptives 
were lactational amenorrhoea if used after 6 months and 
calendar-based methods if used during the first 
12 months post partum. We assumed that as most 
women breastfeed up to 2 years, they would not fulfil the 
initiation requirement of calendar-based methods of 
having at least three regular menstrual cycles before 
12 months.
Participants received individual-based interventions 
during third-trimester antenatal care visits and postnatal 
care follow-up visits according to national practice 
(typically on clinic discharge at 24–48 h after delivery, 
then at 1 week, 6 weeks, then at months 6 and 9 post 
partum) before trial exit at month 12. At each visit, 
providers were instructed to use the counseling tool to 
offer information and services and give women an 
appointment card for the following visit. Providers 
discussed the invitation letter for the partner during the 
first study visit and let the participants choose whether to 
take it. In all study sites, research assistants held a 
journal where they recorded events that could have an 
influence on the implementation or outcomes of the trial 
for its interpretation, but they were not included in the 
analysis and did not modify the trial (eg, staff turnover, 
depletion of stocks of contraceptives, local civil unrest).
Outcomes
The primary outcome was prevalence of use of modern 
contraceptives at month 12 post partum. We amended 
our original protocol14 to extend the follow-up period from 
month 9 to month 12 post partum to allow for better 
comparability with other published research, after the 
initial funder’s research grant deadline was chosen. This 
extension was approved by the ethics committees at 
WHO headquarters and country level. We also reported 
key secondary outcomes after delivery: prevalence of 
modern contraceptive adoption before discharge from the 
health facility (assessed within 48 h after delivery); at 
1 week (assessed on day 7); at 6 weeks (assessed at 
45 days), which coincided with the visit that women are 
encouraged to attend to specifically discuss post-partum 
family planning options as per national recommendations; 
and at 6 months (assessed on the first day of month 6), 
which corresponded to the latest point when transition 
from the lactational amenorrhoea method to another 
modern method should occur. Contraceptive method mix 
was also reported for each measurement point. Serious 
adverse events had to be announced to the principal 
investigator who assessed whether they were related to 
the study.
Statistical analysis 
We used the following assumptions when calculating the 
target population size. Women in the intervention group 
wanting to restrict or space their pregnancies would 
already use a modern contraceptive method at 6 months 
after delivery when the lactational amenorrhoea method 
would no longer be suitable. Therefore, although the 
main study outcome was prevalence of modern 
contraceptive use at 12 months post partum, we used 
country data at 6 months to determine our population 
size. The population size was estimated using the 
2013–14 Demographic and Health Survey data:11 we 
assumed a 5% uptake of modern contraceptives in the 
control group (on the basis of reported prevalence of 
modern contraceptive use of 5% in women at 6 months 
post partum),12 and an increase to 20% in the intervention 
group (on the basis of reported prevalence of modern 
contraceptive use of 15% in women in the general 
population, to which we added 5 percentage points given 
the high unmet need for post-partum family planning).19 
Assuming an intracluster correlation coefficient of 0·02 
(no specific evidence existed for its value from the 
literature),20 the experimental group and the control 
group each had four study sites with at least 
60 participants per site.21 This number allowed for a 
statistical power of 93% to detect a difference of 15% to a 
level of significance of 5% at the individual level (and not 
at the facility level). Assuming a 10% participant loss to 
follow-up, each facility recruited at least 70 pregnant 
women for a cohort of at least 280 pregnant women in 
each study group, and in total at least 560 participants.
The research coordination team at WHO in Geneva 
developed the paper-based study case report forms with 
inputs from the country researchers who tested advanced 
drafts with an appropriate sample of mock clients from 
sites included in the formative study phase. Data for the 
trial were collected by trained research assistants when 
women attended clinic visits or by phone or a home visit 
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when they did not. Data entry was done by the research 
team of the School of Public Health in Kinshasa and 
checked in Geneva by use of OpenClinica (version 3.11).
Data from all eligible participants were analysed with 
IBM SPSS Statistics (version 21.0), R (version 3.4.3), and 
WINPEPI (PEPI-for-Windows, version 11.50). Generalised 
linear mixed models (log binomial and log Poisson) were 
used to assess the effect of the package on prevalence 
ratios (PRs) of main outcomes with 95% CIs, comparing 
intervention and control groups, while accounting for 
clustering and adjusting for potential confounders 
(women’s baseline characteristics that were imbalanced 
between groups). Fisher’s exact test was used when 
samples were small and models did not converge. 
WINPEPI was used to obtain a post-hoc global estimation 
of the intracluster correlation coefficient. We did an 
intention-to-treat analysis that included all women 
irrespective of whether they continued to visit the clinic 
after enrolment. Because women had to see a provider to 
receive the intervention package, we planned to do a per-
protocol analysis focused on participants who attended all 
recommended follow-up visits, but this was not done 
because of low trial completion by participants in both 
groups.
Role of the funding source
The study funder had no role in study design, data 
collection, data analysis, data interpretation, or writing 
the article. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
Of 52 primary clinics assessed for eligibility, eight met the 
criteria and were randomised to the two groups in four 
pairs (four clinics in each group). From July 1, 2016, to 
Feb 2, 2017, of 690 women asked to participate, 576 (83%) 
were enrolled in the study (286 in the intervention group 
and 290 in the control group), of whom 519 (90%; 252 in 
the intervention group and 267 in the control group) 
completed the study exit interview at 12 months and were 
included in the intention-to-treat analysis (full details on 
patient exclusion and loss to follow-up are in figure 2). Exit 
interviews concluded on Feb 1, 2018. More than three-
quarters of women in both groups gave birth in their 
assigned study clinics (216 [79%] of 274 women in the 
intervention group evaluable at the time of delivery and 
216 [77%] of 279 in the control group). Between the 
intervention and control arms, the proportion of timely 
visits differed significantly at 1 week (140 [51%] of 
274 women in the intervention group vs 64 [23%] of 278 in 
the control group, p<0·0001) and 6 months (149 [55%] of 
270 vs 186 [67%] of 275, p=0·0028), but not at 6 weeks 
(165 [61%] of 272 and 159 [58%] of 276, p=0·47). 
The proportion of participants who attended all the 
recommended follow-up visits from clinic discharge to 
12 months post partum differed significantly between the 




8 clinics randomly assigned to the cluster RCT
690 women approached
3 clinics randomly assigned to the formative phase
52 primary clinics with maternity care assessed 
for eligibility
 
41 clinics excluded (<30 deliveries per month)






32 declined to participate
279 women with information available at 48 h after 
delivery
216 women delivered in study clinic
 
274 women with information available at 48 h after 
delivery
216 women delivered in study clinic
1 maternal death
11 lost to follow-up
278 women with information available at 1 week
64 women actually attended the visit
274 women with information available at 1 week 
140 women actually attended the visit
0 excluded
276 women with information available at 6 weeks
159 women actually attended the visit
272 women with information available at 6 weeks
165 women actually attended the visit
 
2 lost to follow-up
275 women with information available at 6 months
186 women actually attended the visit
 
270 women with information available at 6 months 
149 women actually attended the visit 
1 withdrew 
1 lost to follow-up
267 women with information available at 12 months 
45 ineligible
13 declined to participate
3 withdrew 








3 lost to follow-up
2 interrupted the study
 
252 women with information available at 12 months 
2 withdrew 
1 maternal death 
6 lost to follow-up
9 interrupted the study
Figure 2: Trial profile
RCT=randomised controlled trial.
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two groups (p<0·0001) with 39 (15%) of 252 in the 
intervention group versus six (2%) of 267 in the control 
group. As only six participants in the control group and 
39 in the intervention group completed all recommended 
visits, per-protocol analysis was not done. Between the 
intervention and control groups, some baseline differences 
were noted (table 1), including education level, living 
setting, usual travel time to health centre, and employment.
At 12 months post partum, the prevalence of use of 
modern contraceptives in the intervention group was 
not significantly different from that in the control 
group (115 [46%] of 252 women in the intervention group 
vs 94 [35%] of 267 in the control group; adjusted PR 1∙58, 
95% CI 0∙74−3∙38; table 2). The prevalence ratio of 
long-acting contraceptive use in the intervention group 
was more than four times higher than that in the 
control group, mostly because of implants (table 2). In 





General characteristics of women
Median maternal age, years 28 (15–46) 28 (15–42)
Marital status
Married or in a relationship 264 (92%) 262 (90%)
Single, widow, separated, or 
divorced
22 (8%) 28 (10%)
Education level
Never attended school 7 (2%) 5 (2%)
Primary school 38 (13%) 67 (23%)
Secondary school 187 (65%) 184 (63%)
Higher education 54 (19%) 34 (12%)
Able to read an official language 249 (87%) 259 (89%)
Living setting
Suburban 282 (99%) 117 (40%)
Urban 4 (1%) 173 (60%)
Employment
Housewife or farmer 196 (69%) 110 (38%)
Student 11 (4%) 13 (5%)
Business 20 (7%) 18 (6%)
Other 59 (21%) 149 (51%)
Usual travel time to health centre
<30 min 137/219 (63%) 68/282 (24%)
30–60 min 61/219 (28%) 164/282 (59%)
>1 h 21/219 (10%) 50/282 (18%)
Maternity and contraception
Previous pregnancies
Yes 233 (81%) 229 (79%)
Median number 2 (0–11) 2 (0–9)
Livebirths 210/233 (90%) 214/229 (93%)
Living biological children
Yes 210/233 (90%) 212/229 (93%)
Median number 2 (0–9) 2 (0–8)
Age of last child
≥2 years 175/207 (84%) 184/212 (87%)
Breastfeeding of last child 216/233 (93%) 212/229 (93%)
Length of exclusive breastfeeding, 
months
210/233 (90%) 212/229 (93%)
<1 17/210 (8%) 7/212 (3%)
1–5 127/210 (61%) 128/212 (60%)
≥6 66/210 (31%) 77/212 (37%)
Interpregnancy interval, years
≥2 121/230 (53%) 133/226 (59%)
<2 109/230 (47%) 93/226 (41%)





(Continued from previous column)
Current pregnancy
Planned 92 (32%) 84/281 (30%)
Any place of delivery 274 (96%) 274/281 (98%)
Delivered in study health centre 241/274 (88%) 235/274 (84%)
Main reason of non-use of 
contraception
146 (51%) 139 (48%)
Did not know about methods 84/146 (58%) 60/139 (43%)
Wanted pregnancy 24/146 (16%) 33/139 (24%)
Partner or family opposition 21/146 (14%) 6/139 (4%)
Fear of side-effects 10/146 (7%) 17/139 (12%)
Other 7/146 (5%) 23/139 (17%)
Contraception during year before 
pregnancy
140 (49%) 151 (52%)
Injectable 7/140 (5%) 11/151 (7%)
Pill 17/140 (12%) 15/151 (10%)
Implant 6/140 (4%) 8/151 (5%)
Male condom 34/140 (24%) 14/151 (10%)
Standard-day method 31/140 (22%) 41/151 (27%)
Intrauterine device 0 2/151 (1%)
Traditional methods 45/140 (32%) 60/151 (43%)
General characteristics of male partners*
Age reported 233 (81%) 222 (77%)
Median age, years 35 (17–57) 35 (20–69)
Education level, 264 262
Never attended school 3 (1%) 4 (1%)
Primary school 7 (3%) 19 (7%)
Secondary school 154 (59%) 143 (55%)
Higher education 100 (38%) 96 (37%)
Able to read an official language 258 251
Yes 251 (97%) 246 (98%)
Employment 264 261
None 27 (10%) 14 (5%)
Student 2 (1%) 1 (1%)
Farmer 10 (4%) 2 (1%)
With regular salary 113 (43%) 96 (37%)
Business 21 (8%) 30 (11%)
Crafts 2 (1%) 18 (7%)
Other 89 (34%) 100 (38%)
Data are N, n/N (%), or median (range). *Information collected from the enrolled 
women about their partners; male partners were not interviewed directly.
Table 1: Baseline characteristics of study population at enrolment
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Modern and appropriate methods 115 (46%) 94 (35%) 1·58 (0·74–3·38)
Long-acting or permanent methods 56 (22%) 18 (7%) 4·47 (2·05–9·74)
Implant 55 (22%) 16 (6%) 4·36 (1·96–9·70)
Intrauterine device 1 (<1%) 2 (1%) 0·53 (0·49–2·05)†
Female sterilisation 0 0 0
Vasectomy 0 0 0
Short-acting methods 59 (23%) 76 (28%) 0·92 (0·29–2·98)
Injectable 20 (8%) 23 (9%) 1·20 (0·31–4·60)
Pill 12 (5%) 22 (9%) 0·75 (0·29–1·95)
Male condom 27 (11%) 27 (10%) 1·02 (0·31–3·40)
Female condom 0 0 0
Emergency contraception 0 4 (2%) 0‡
Spermicide 0 0 0
Non-modern or inappropriate methods 18 (7%) 47 (18%) 0·45 (0·13–1·54)
Lactational amenorrhoea method 0 0 0
Withdrawal 2 (1%) 9 (3%) 0·09 (0·02–0·49)
Abstinence 2 (1%) 3 (1%) 1·81 (0·15–22·44)
Standard-day method 11 (4%) 32 (12%) 0·38 (0·08–0·31)
Others 3 (1%) 3 (1%) 0·99 (0·03–34·68)
No method 119 (47%) 126 (47%) 0·84 (0·31–2·24)
Data are n (%). PR=prevalence ratio. *Accounting for clustering effect and adjusted for living setting, education level, 
employment, and usual travel time to health centre. †Adjusting for clustering effect not possible. ‡Two-sided p value 
Fisher’s exact test >0·05.
Table 2: Prevalence of use of contraceptive methods at 12 months post partum
devices and no one opted for sterilisation. The use of 
short-acting contra ceptives was comparable between 
both study groups, with a preference for male condoms, 
injectables, and pills. The proportions of users of 
short-acting and long-acting contraceptives were similar 
in the intervention group, whereas women in the control 
group were four times more likely to use short-acting 
than long-acting contraceptives. Women in the 
intervention group tended to resort less to non-modern 
or inappropriate methods than their counterparts in the 
control group, with the standard-day method being the 
most common, followed by withdrawal.
Findings at 12 months reflected earlier similar trends in 
both groups: implant uptake was already reported at 48 h 
in the intervention group and increased at each of the 
follow-up timepoints (table 3). Conversely, women in the 
control group began using implants only at 6 months 
(only one woman opted for an implant at 6 weeks; table 3). 
By comparison, uptake of short-acting contraceptives was 
reported earlier in the control group than in the 
intervention group and also increased at each of the 
follow-up timepoints, with male condoms being the most 
prevalent, followed by pills and injectables (table 3). At 
6 weeks, a significantly higher proportion of women in 
the control group already reported the use of non-modern 
or inappropriate methods (mainly with drawal), compared 
with women in the intervention group (table 3). However, 
at 6 months, the difference between women who used 
non-modern or inappropriate methods was already not 
significant (table 3). In both groups, few women used the 
lactational amenorrhoea method or intrauterine devices 
and none chose sterilisation (table 3). The post-hoc global 
estimation of the intracluster correlation coefficient was 
0∙153 (0∙121 for the inter vention group and 0∙184 for the 
control group).
Three of the four control health centres (Esengo, 
Libondi, and Mama Mosalisi) benefited from family 
planning activities that were initiated by other non-
governmental organisations after study enrolment 
started. These activities, albeit not focused on post-
partum family planning, were linked to HIV or family 
planning programming and were also offered to women 
post partum, including to Yam Daabo participants. 
The Esengo facility received support from the US Agency 
for International Development to deliver free family 
planning services, including long-acting and reversible 
contraceptives. The Libondi centre was supported by the 
Global Fund, Pathfinder, and the International Center for 
AIDS Care and Treatment Programs for free contraceptive 
methods and services (except for implant, for which the 
method was free but insertion services were not). The 
Elisabeth Glaser Pediatric Aids Foundation backed the 
Mama Mosalisi site with free condom distribution and 
other family planning methods and services (except for 
implant, for which the method was free but insertion 
services were not). None of the other study sites reported 
support from external partners with potential impact on 
modern contraceptive uptake.
Discussion
Although not significant for the primary outcome, the 
results of the Yam Daabo trial in DR Congo were overall 
consistent with those from rural Burkina Faso. They 
showed that a package strategy combining six low-
technology interventions focusing on post-partum family 
planning was effective in increasing the use of modern 
contraceptives, particularly implants, up to 12 months 
after childbirth in women from urban settings in 
Kinshasa. Along with its twin study in rural Burkina Faso, 
our study was, to our knowledge, pioneering research 
using a post-partum family planning package approach 
in Africa. It adds to the relatively scarce literature on the 
effectiveness of different intervention packages on post-
partum contraceptive use. The Yam Daabo package 
showed several differences and similarities in its 
implementation in Burkina Faso and DR Congo.
First, the dynamic of overall prevalence of modern 
contraceptive use over 12 months and the resulting PRs 
and level of significance differed between countries. An 
explanation might be the fact that the integrity of routine 
care in control facilities in DR Congo was compromised 
by the unforeseen family planning activities initiated by 
other non-governmental organisations. In terms of the 
prevalence dynamic, the use of modern contraceptives in 
the intervention groups in both countries increased from 
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the time of clinic discharge up to 12 months post partum. 
This dynamic differed in the control groups, as the 
prevalence in Burkina Faso did not change from month 6 
to month 12, when it reached 29%, a proportion that did 
not overtake the 30% in national prevalence projected 
for 2018.22 In DR Congo, however, the prevalence in the 
control group kept increasing until 12 months, when it 
reached 35% and surpassed by 8 percentage points the 
27% in projected prevalence for 2017 for married women 
in Kinshasa.23 It was unlikely that women from control 
study sites went to intervention sites to receive the 
package, or that components of the package reached 
contraceptive services in control sites, as neither situations 
were reported by service providers or research assistants 
assigned to each of the centres. Instead, externally funded 
family planning activities documented by the research 
team in three of the four control sites probably affected 
the uptake of modern contraceptives. With few resources 
and investments from the Ministry of Health, most of the 
health programmes and facilities in DR Congo have been 
relying on external sources of support.24 Although it was a 
prerequisite for health centres to be free from other 
family-planning-related support at the time of study site 
enrolment, we could not prevent centres from receiving 
other programmatic assistance for family planning during 
the study period. As this was a pragmatic trial, which 
reflected real-life settings and events, we decided to 
pursue the study course regardless of the confounding 
effect of external programmatic assistance. In the end, the 
Yam Daabo intervention package was compared with 
other interventions that had relevant family planning 
components and were offered to women in the control 
group.
Second, although the 12-month PR in Kinshasa was 
not significant probably because of these interferences, it 
is important to emphasise the clinically significant 
differences in the types of contraceptive methods 
between the intervention and control groups: long-acting 
and reversible methods are well known to fail less 
often than short-acting methods.25 The mix of modern 
contraceptive methods in the intervention group 
reflected, to some extent, the one reported in Kinshasa 
in 2017 (38% implants, 2% intrauterine devices, 
20% injectables, 17% pills, 17% male condoms, and 
6% other methods).23 As in Burkina Faso, women in the 
intervention group in Kinshasa used more implants, 
which have a failure rate of 0∙05% within the first year of 
typical use and are therefore more cost-effective than 
short-acting methods for pregnancy prevention (male 
condoms have a failure rate of 18%, pills 9%, and 
injectables 6%).25 In Burkina Faso, there was no 
difference between groups regarding the use of non-
modern inappropriate contra ceptives, unlike in Kinshasa 
where more women in the control group tended to use 
such methods, including withdrawal or methods based 
on fertility awareness, which have a typical failure rate of 
use of 22% and 24%.25
When compared with general contraceptive services that 
are not offered post partum, providers’ specialised 
knowledge of the appropriate timing of different 
contraceptive methods after childbirth, breastfeeding 
status, or menstrual return is crucial for effective post-
partum counselling of family planning and contraceptive 
method provision. For instance, the 2015 revision of 
WHO’s medical eligibility criteria for contraceptive use 
allowed implants for all women post partum without 
restriction. This is a key change in clinical practice, 
especially for auxiliary midwives or nurses who typically 
staff primary health-care centres and are allowed to provide 
implants but not intrauterine devices. This revision was 
disseminated nationwide by the Ministry of Health with 
key changes related to post-partum contraceptives 
integrated into the Yam Daabo counselling tool. As such, 
although our approach did not focus on a specific method 
to the detriment of another, results showed that women in 








Modern and appropriate methods 9 (3%) 3 (1%) 1·83 (0·43–7·74)
Long-acting or permanent methods 6 (2%) 0 0†
Implant 5 (2%) 0 0†
Intrauterine device 1 (<1%) 0 0
Female sterilisation 0 0 0
Vasectomy 0 0 0
Short-acting methods 0 2 (1%) 0
Pill 0 0 0
Male condom 0 2 (1%) 0
Female condom 0 0 0
Spermicide 0 0 0
Lactational amenorrhoea method 3 (1%) 1 (<1%) 2·60 (0·20–33·60)
Non-modern or inappropriate methods 1 (<1%) 0 0
Abstinence 1 (<1%) 0 0
No method 264 (96%) 276 (99%) 0·98 (0·77–1·24)
1 week
Modern and appropriate methods 15 (5%) 3 (1%) 2·09 (0·78–10·75)
Long-acting or permanent methods 12 (4%) 0 0
Implant 11 (4%) 0 0
Intrauterine device 1 (<1%) 0 0
Female sterilisation 0 0 0
Vasectomy 0 0 0
Short-acting methods 0 2 (1%) 0
Pill 0 0 0
Male condom 0 2 (1%) 0
Female condom 0 0 0
Spermicide 0 0 0
Lactational amenorrhoea method 3 (1%) 1 (<1%) 2·51 (0·20–31·11)
Non-modern or inappropriate methods 1 (<1%) 1 (<1%) 1·01 (0·06–16·14)‡
Abstinence 1 (<1%) 1 (<1%) 1·01 (0·06–16·14)‡
No method 258 (94%) 274 (99%) 0·96 (0·75–1·22)
(Table 3 continues on next page)
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more likely to adopt contraceptives with higher 
effectiveness and were less likely to use non-modern or 
inappropriate methods, such as withdrawal or standard-
day method than women in the control group.
Third, Yam Daabo’s low-dose, high-frequency approach 
encouraged women to attend routinely recommended 
follow-up visits to ensure time-appropriate contraceptive 
uptake. In Burkina Faso, client counselling supported by 
the post-partum family planning tool, in conjunction with 
appointment card distribution, might have contributed to 
significant differences in timely visits, with more women 
in the intervention group attending scheduled visits at 
6 weeks (64%) than women in the control group (34%) 
and 6 months (16% vs 6%). However, results in Kinshasa 
showed no difference at 6 weeks and a marked difference 
in visits at 6 months in favour of the control group. This 
higher attendance in the control group could further 
indicate the interference in routine care that other family 
planning-related activities (eg, free family planning 
services and methods, including for long-acting contra-
ceptives) potentially exerted on control sites.
Fourth, as for the very infrequent use of lactational 
amenorrhoea as a contraceptive method on facility 
discharge, at 1 week, 6 weeks, and 6 months post partum, 
results in Kinshasa did not contrast with those from 
Burkina Faso and reflected the situation in other low-
income countries, where early supplementation of 
breastfeeding with other fluids anchored in customary 
practices are common.26
Fifth, our study contributed to a global post-hoc 
estimation of the intracluster coefficient, which was 
about 0·15, and larger than the initially assumed value of 
0·02 and the 0·03 estimated post hoc in the Burkina 
Faso trial. Under this assumption of 0·15, the power to 
detect the expected difference is low at less than 50%, 
which is consistent with the non-significant results for 
the primary outcome. The post-hoc estimation of the 
intracluster coefficient was not as large for other relevant 
outcomes, such as the prevalence of long-acting or 
permanent methods at 12 months, which was 0·01.
There were several limitations to our study. First, the 
integrity of routine care in three of the four control sites 
could not be preserved during the study period. In 
DR Congo, the Yam Daabo intervention package was 
not compared with typical routine care, but with other 
family-planning-related activities. Additionally, incorp-
oration of elements of the package into other sites could 
not be fully excluded. However, our post-partum family-
planning-focused intervention, compared with other 
family-planning-related activities in control sites, proved 
more effective in enabling women to find a combination 
of contraceptive methods that reduced the use of non-
modern or inappropriate methods and offered increased 
pregnancy protection. Second, the trial included eight 
clusters that were enough according to our statistical 
hypotheses but were still relatively few, potentially 
increasing the risk of groups not being fully similar. 
Third, this pragmatic trial based in health centres did not 
permit masking of participants, providers, and research 
assistants, and we could not rule out assessment or 







(Continued from previous page)
6 weeks
Modern and appropriate methods 32/272 (12%) 16/276 (6%) 6·79 (0·86–53·79)
Long-acting or permanent methods 21/272 (8%) 1/276 (<1%) 72·37 (4·75–1103·82)
Implant 20/272 (7%) 1/276 (<1%) 66·10 (4·33–1009·06)
Intrauterine device 1/272 (<1%) 0 0
Female sterilisation 0 0 0
Vasectomy 0 0 0
Short-acting methods 9/272 (3%) 15/276 (5%) 3·21 (0·02–651·22)
Injectable 1/272 (<1%) 0 0
Pill 0 0 0
Male condom 8/272 (3%) 15/276 (5%) 2·07 (0·00–4238·70)
Female condom 0 0 0
Emergency contraception 0 0 0
Spermicide 0 0 0
Lactational amenorrhoea method 2/272 (<1%) 0 0
Non-modern or inappropriate methods 3/272 (1%) 19/276 (7%) 0·10 (0·01–0·90)
Withdrawal 1/272 (<1%) 9/276 (3%) 0·06 (0·00–0·91)
Abstinence 2/272 (1%) 8/276 (3%) 0·23 (0·04–1·24)
Standard-day method 0 1/276 (<1%) 0
Others 0 1/276 (<1%) 0
No method 237/272 (87%) 241/276 (87%) 1·17 (0·89–1·52)
6 months
Modern and appropriate methods 82/269 (30%) 58/275 (21%) 1·58 (0·60–4·15)
Long-acting or permanent methods 41/269 (15%) 12/275 (4%) 3·43 (1·39–8·48)
Implant 40/269 (14%) 10/275 (4%) 4·06 (1·58–10·40)
Intrauterine device 1/269 (<1%) 2/275 (1%) 0·92 (0·04–23·32)
Female sterilisation 0 0 0
Vasectomy 0 0 0
Short-acting methods 40/269 (15%) 46/275 (17%) 1·04 (0·26–4·14)
Injectable 13/269 (5%) 5/275 (2%) 5·24 (1·02–26·85)
Pill 4/269 (1%) 8/275 (3%) 1·09 (0·20–5·89)
Male condom 23/269 (9%) 29/275 (11%) 0·58 (0·07–4·83)
Female condom 0 0 0
Emergency contraception 0 4/275 (1%) 0
Spermicide 0 0 0
Lactational amenorrhoea method 1/269 (<1%) 0 0
Non-modern or inappropriate methods 16/269 (6%) 30/275 (11%) 0·64 (0·11–3·78)
Withdrawal 5/269 (2%) 9/275 (3%) 0·28 (0·08–1·01)
Abstinence 2/269 (1%) 1/275 (<1%) 2·04 (0·19–22·42)†
Standard-day method 9/269 (3%) 15/275 (6%) 0·65 (0·15–2·72)
Others 0 5/275 (2%) 0
No method 171/269 (64%) 187/275 (68%) 0·88 (0·43–1·79)
Data are n (%) or n/N (%), unless otherwise indicated. PR=prevalence ratio. *Accounting for clustering effect and 
adjusted for living setting, education level, employment, and usual travel time to health centre. †2-sided p value 
Fisher’s exact test >0·05. ‡Adjusting for clustering effect not possible.
Table 3: Prevalence of use of contraceptive methods at 48 hours, 1 week, 6 weeks, and 6 months post 
partum
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effect size due to bias towards socially desirable answers, 
especially in this facility-based research, although inde-
pendent research assistants were employed. However, 
information bias and assessment bias could not alone 
contribute to the increased use of effective contraceptives 
reported at different measure ment points. Fifth, policy 
makers and programme managers might prefer a single 
most effective intervention over a package approach. 
Our research design was not meant to discriminate 
which intervention in the package had the greatest effect 
on contraceptive use, for which additional research 
would be needed. However, inter ventions were selected 
on the basis of the perspectives of multiple stakeholders 
and integrated into the package because they were 
perceived to be simple, easily accessible, and adapted to 
resource-constrained settings, while strengthening exist-
ing services, making them easy to implement and 
replicate. Sixth, women using modern contraceptives at 
12 months should be followed up until 2 years and 
beyond to study their patterns of contraceptive use and 
evaluate whether they continue to be more successful in 
limiting or spacing pregnancies according to their 
reproductive choices. We acknowledge the limitations of 
using prevalence of modern contraceptive use as our 
primary outcome because there is potential for 
contraceptive uptake to be encouraged to achieve targets, 
without accounting for women’s or couples’ fertility 
intentions and their right to determine the timing of 
their pregnancies.
Reflecting the effectiveness of a similar intervention 
package in rural Burkina Faso, the implementation in 
urban settings of six low-technology, post-partum family 
planning interventions established through multi-
stakeholder participation increased the proportion of 
women choosing modern contraceptives post partum, 
and in particular implants, while avoiding the use of 
less effective methods up to 12 months after childbirth. 
Other primary health centres in Kinshasa or in similar 
urban settings in DR Congo or other countries could 
benefit from introducing a similar package to reduce 
the unmet need for family planning in women and 
couples post partum.
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